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Sustained macroautophagy/autophagy favors the differentiation of fibroblasts into 
myofibroblasts. Cellular senescence, another means of responding to long-term cellular stress, 
has also been linked to myofibroblast differentiation and fibrosis. Here, we evaluate the 
relationship between senescence and myofibroblast differentiation in the context of sustained 
autophagy. We analyzed markers of cell cycle arrest/senescence in fibroblasts in vitro, where 
autophagy was triggered by serum starvation (SS). Autophagic fibroblasts expressed the 
senescence biomarkers CDKN1A/p21 and CDKN2A/p16 and exhibited increased senescence-
associated GLB1/beta-galactosidase activity. Inhibition of autophagy in serum-starved 
fibroblasts with 3-methyladenine, LY294002, or ATG7 (autophagy related 7) silencing 
prevented the expression of senescence-associated markers. Similarly, suppressing MTORC2 
activation using rapamycin or by silencing RICTOR also prevented senescence hallmarks. 
Immunofluorescence microscopy showed that senescence and myofibroblast differentiation 
were induced in different cells, suggesting mutually exclusive activation of senescence and 
myofibroblast differentiation. Reactive oxygen species (ROS) are known inducers of senescence 
and exposing fibroblasts to ROS scavengers decreased ROS production during SS, inhibited 
autophagy, and significantly reduced the expression of senescence and myofibroblast 
differentiation markers. ROS scavengers also curbed the AKT1 phosphorylation at Ser473, an 
MTORC2 target, establishing the importance of ROS in fuelling MTORC2 activation. Inhibition 
of senescence by shRNA to TP53/p53 and shRNA CDKN2A/p16 increased myofibroblast 
differentiation, suggesting a negative feedback loop of senescence on autophagy-induced 
myofibroblast differentiation. Collectively, our results identify ROS as central inducers of 
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MTORC2 activation during chronic autophagy, which in turn fuels senescence activation and 
myofibroblast differentiation in distinct cellular subpopulations. 
Keywords: autophagy, CDKN1A, CDKN2A, differentiation, fibroblast, MTORC2, 
myofibroblast, rapamycin, ROS, senescence.  
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The differentiation of fibroblasts into myofibroblasts is an essential component of 
normal tissue repair. Differentiated myofibroblasts are characterized by a contractile phenotype 
dependent on the formation of stress fibers that contain ACTA2 (actin alpha 2, smooth muscle) 
and an increased capacity to produce extracellular matrix (ECM) components such as COL1A 
(collagen type I alpha) and COL3A1 [1,2]. During fibrosis, an abnormal form of repair, 
myofibroblasts persist at sites of injury, therefore contributing to ECM protein overproduction, 
ECM thickening, loss of normal tissue architecture, and perturbed organ and/or tissue functions 
[1,3]. The presence of myofibroblasts during the healing process is, therefore, a normal 
phenomenon, while their long-term accumulation is a hallmark of fibrosis. 
Cellular senescence refers to a stable arrest of cell proliferation. This process results from 
a variety of stresses including oxidative stress, telomere attrition and activated  
oncogenes [4]. Senescence-associated proliferation arrest is characterized by the activity of the 
TP53-CDKN1A/p21WAF1 and CDKN2A/p16INK4a-RB pathways. Senescent cells also increase 
lysosomal mass to promote elevated levels of senescence-associated GLB1/beta-galactosidase 
(SA-GLB1/β-gal) activity [5]. They remain viable and contribute to the tissue stress response 
mostly via a senescence-associated secretory phenotype [6,7]. Mounting evidence suggests that 
dysregulated senescence can, under certain circumstances, contribute to abnormal tissue repair 
and fibrosis [6,8]. Both enhanced [9] and decreased [10,11] cellular senescence have been linked 
to fibrosis. These seemingly contradictory results likely highlight the fact that finely-tuned 
levels of senescence are required during normal tissue repair, whereas unregulated senescence 
likely disrupts normal healing [8,12]. Hence, the timing of the senescence response, the cell 
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types involved, and the downstream pathways triggered by senescence induction weave a 
complex interplay of responses that may be either beneficial or detrimental to tissue repair.  
Autophagy represents a highly conserved process triggered, like senescence, in response 
to stress or starvation. During autophagy, cytoplasmic components are sequestered within 
autophagosomes, which fuse with lysosomes to initiate the degradation of its content to sustain 
metabolism. Mechanistic target of rapamycin kinase complex 1 (MTORC1) is a key regulator 
of autophagy, and its inhibition increases this cellular process [13]. Autophagy has also been 
linked to fibrosis [14,15]. It was shown to promote fibroblast-to-myofibroblast differentiation 
through activation of the mechanistic target of rapamycin kinase complex 2 (MTORC2) [16,17].  
Studies on cross-talk between autophagy and senescence in fibroblasts show 
contradictory context-dependent results [18,19]. In the context of chemotherapy- or oncogenic 
Ras-induced senescence, the inhibition of autophagy delays the expression of senescence 
markers [20,21]. In contrast, primary human cells prematurely enter telomere- and stress-
mediated replicative senescence when autophagy is perturbed [22]. In addition to senescence-
associated proliferation arrest, autophagy is also involved in regulating the pro-inflammatory 
secretome of senescent cells [23], whether senescence impacts autophagy-mediated MTORC2 
activation and myofibroblast differentiation remain to be delineated.  
Here, we sought to characterize the interlaced relationship between autophagy-induced 
MTORC2 activation in fibroblasts and senescence activation. We report that, in fibroblasts, 
sustained autophagy induction by reactive oxygen species (ROS) is associated with enhanced 







Autophagy induced by prolonged serum starvation is central to senescence.  
 
WI-38 human embryonic lung fibroblasts were exposed to serum-free/serum starvation medium 
(SS) to evaluate the functional importance of growth factor deprivation in the simultaneous 
activation of autophagy, senescence, and myofibroblast differentiation. CDKN1A (cyclin 
dependent kinase inhibitor 1A) protein, a marker of both cell-cycle arrest and senescence [24], 
increased rapidly in fibroblasts serum-starved for 4 h followed by a progressive decline, 
suggesting a role in immediate growth arrest (Fig. 1A). Alternatively, CDKN2A (cyclin 
dependent kinase inhibitor 2A), another cell-cycle arrest protein, and a reliable cell senescence 
marker [25-28] was stably induced in serum-starved fibroblasts (Fig. 1B). SA-GLB1/β-gal 
activity, another cell senescence marker [29] was also induced in fibroblasts serum-starved for 
7 d (Fig. 1C). As reported previously [16], prolonged serum starvation decreased SQSTM1/p62 
(sequestosome 1) protein level, a marker of autophagy induction, and increased ACTA2/αSMA 
protein level, a marker of myofibroblast differentiation (Fig. 1A and 1B). These results suggest 
that the induction of autophagy is associated with the concomitant induction of senescence and 
myofibroblast differentiation in serum-starved fibroblasts. Adult human lung fibroblasts (HLF) 
exposed to prolonged serum starvation also displayed evidence of autophagy, senescence, and 
myofibroblast differentiation (Fig. S1A). 
We next evaluated whether markers of senescence were directly modulated by autophagy. Class 
III phosphatidylinositol 3-kinase (PtdIns3K) activity is necessary for autophagosome formation 
[30]. Therefore, we used PtdIns3K inhibitors 3-methyladenine (3-MA) and LY294002 (LY), 2 
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inhibitors that curtail both class I phosphoinositide 3-kinase/PI3K and Ptdlns3K activity in 
starved cells [31-33]. As expected, 3-MA and LY prevented the enhancement of lipidated 
MAP1LC3B (microtubule associated protein 1 light chain 3 beta) to nonlipidated (MAP1LC3B-
II:I) ratios, increased SQSTM1 expression and blocked ACTA2 upregulation in WI-38 cells 
(Fig. 2A and 2B). Starved HLF cells showed a similar response (Fig. S1B). 3-MA and LY also 
inhibited CDKN1A and CDKN2A upregulation as well as SA-GLB1/β-gal activity in serum-
starved fibroblasts (Fig. 2A, 2B, 2D, 2E, and S1B). To further assess the importance of 
sustained autophagy in the induction of senescence markers, we silenced ATG7 [34] in serum-
starved fibroblasts. siATG7 decreased MAP1LC3B-II:I ratios, increased SQSTM1 protein level 
and prevented ACTA2 and CDKN2A overexpression (Fig. 2C). These results indicate that 
autophagy is instrumental in triggering both senescence and myofibroblast differentiation. 
 
MTORC2 signaling regulates autophagy-induced senescence. 
 
MTORC2 is responsible for AKT1 (AKT serine/threonine kinase 1) phosphorylation at Ser473 
[35]. We previously showed that prolonged autophagy activates MTORC2 leading to AKT1 
phosphorylation at Ser473 [16]. Inhibiting MTORC2 with rapamycin (R) [35] or by silencing 
RICTOR (RPTOR independent companion of MTOR complex 2), an essential component of 
MTORC2 [36] suppresses AKT1 phosphorylation at Ser473 in serum-starved fibroblasts [16]. 
These results prompted us to investigate whether the expression of senescence markers in 
fibroblasts exposed to prolonged SS is also under MTORC2 control.  
Prolonged exposure of serum-starved fibroblasts to rapamycin prevented phosphorylation of the 
MTORC2 target AKT1 without reducing MAP1LC3B-II:I ratios in WI-38 (Fig. 3A). Serum-
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starved fibroblasts exposed to R showed lowered CDNK1A and CDKN2A protein levels and 
decreased SA-GLB1/β-gal activity (Fig. 3A, 3C, and S1C). Long-term R treatment of serum-
starved fibroblasts also reduced ACTA2 expression (Fig. 3A and S1C). To tease out the 
respective roles of MTORC2 and MTORC1 complexes, we silenced either RICTOR, an integral 
component of MTORC2 or RPTOR (regulatory associated protein of MTOR complex 1) an 
essential component of MTORC1 in serum-starved fibroblasts (Fig. 3). RICTOR silencing 
suppressed AKT1 phosphorylation at Ser473 along with repression of myofibroblast 
differentiation inhibition of CDKN1A and CDKN2A expression, and inhibition of SA-GLB1/β-
gal activity (Fig. 3B and 3D). Silencing RPTOR did not inhibit AKT1 phosphorylation or 
ACTA2 overexpression and did not reduce levels of CDKN1A and CDKN2A (Fig. 3B). RPTOR 
silencing led, however, to inhibition of SA-GLB1/β-gal activity (Fig. 3D). This result suggested 
that both MTORC1 and MTORC2 activities control senescence through distinct downstream 
signaling pathways. To further test this possibility, we silenced RICTOR and RPTOR 
concomitantly in serum-starved fibroblasts. This silencing led to a further reduction in SA-
GLB1/β-gal activity, confirming that RICTOR and RPTOR modulate distinct and additive 
pathways (Fig. 3D). These results suggest that MTORC2 activation induced by prolonged 
autophagy concomitantly controls the expression of senescence markers and myofibroblast 
differentiation through signaling pathways that are independent of MTORC1.  
 
ROS are involved in MTORC2-signaling, senescence and myofibroblast differentiation 




ROS are well-described inducers of autophagy [37] and senescence [38] and are also known to 
regulate myofibroblast differentiation [39]. We sought to investigate the role played by ROS in 
autophagy-induced senescence and myofibroblast differentiation. First, we evaluated ROS 
production in serum-starved fibroblasts. Cells starved for 1 or 4 h showed increased ROS (Fig. 
4A). Incubating cells with N-acetyl-L-cysteine (NAC) or L-glutathione reduced (GSH), 2 ROS 
scavengers, during SS blocked ROS production in serum-starved cells (Fig. 4A and S1D) and 
prevented mitochondrial fragmentation induced by long-term serum starvation (Fig. S2). NAC 
and GSH restored SQSTM1 expression, prevented CDKN1A and CDKN2A overexpression, 
and inhibited the up-regulation of ACTA2 (Fig. 4B and S1D). NAC and GSH also prevented 
increased SA-GLB1/β-gal activity (Fig. 4C and S1D). We, therefore, tested whether ROS are 
central to MTORC2 activation in serum-starved fibroblasts. Scavenging ROS in serum-starved 
fibroblasts with NAC and GSH significantly reduced AKT1 phosphorylation at Ser473 (Fig. 4D 
and S1D). These results indicate that, in serum-starved fibroblasts, increased ROS production 
is a central trigger for autophagy induction, which, in turn, activates MTORC2 and evokes 
downstream induction of senescence and myofibroblast differentiation. 
 
Inhibition of senescence leads to enhanced myofibroblast differentiation. 
 
To explore the relationship between senescence pathways and myofibroblast differentiation, we 
used RNA interference to stably suppress the expression of the 2 key senescence genes CDKN2A 
and TP53 (tumor protein p53), the upstream regulator of CDKN1A, in serum-starved fibroblasts 
[5,26,40]. Using lentiviral vectors, we sequentially introduced 2 short hairpin RNA (shRNA), 
shRNACDKN2A and shRNATP53, into proliferating WI38 cells to create shTP53CDKN2A cells, 
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and alternatively created control cells that express a non-specific shRNA (shGFP cells). Unlike 
shGFP cells, serum-starved shTP53CDKN2A fibroblasts showed significant suppression of 
CDKN2A and CDKN1A expression (Fig. 5A), and inhibition of senescence, as demonstrated 
by decreased SA-GLB1/β-gal activity (Fig. 5B). Blocking activation of senescence prevented 
MTORC2 activation as demonstrated by reduced AKT1 phosphorylation at Ser473 (Fig. 5A). 
We then evaluated the impact of senescence inhibition on myofibroblast differentiation. 
Intriguingly, we found that serum-starved shTP53CDKN2A fibroblasts displayed increased 
myofibroblast differentiation, as shown by increased ACTA2. This observation occurred in spite 
of decreased MTORC2 activation (Fig. 5A). These results suggest that autophagy-induced 
senescence activation favors MTORC2 activation but represses myofibroblast differentiation.  
 
Cellular senescence and myofibroblast differentiation are not concomitantly activated in the 
same cells. 
 
We then evaluated whether senescence and myofibroblast differentiation occur in the same cells 
or distinct cell subpopulations in response to autophagic stress. C12FDG (5-
dodecanoylaminofluorescein di-β-D-galactopyranoside) is a β-galactosidase substrate, and its 
cleavage by β-galactosidase produces a fluorescent product retained by the cells. Using 
C12FDG and immunofluorescent staining of ACTA2, we found that increased SA-GLB1/β-gal 
activity and ACTA2 overexpression are generally found in distinct cell subpopulations in serum-
starved fibroblasts (Fig. 6 and S3). These results suggest that chronic autophagy evokes either 





Previous work has shown that autophagy and senescence affect tissue repair that can, in turn, 
result in fibrosis [6,8,14,41]. In the present study, we focus on fibroblasts and the links between 
autophagy, senescence, and myofibroblast differentiation. We found that ROS and sustained 
autophagy induce MTORC2 activity and that MTORC2 signaling concomitantly activates 
senescence and myofibroblast differentiation. We also show that senescence favors sustained 
MTORC2 activation while at the same time preventing myofibroblast differentiation.  
The role of autophagy in cellular senescence has been studied in the context of oncogene 
activation [20,42], replicative senescence [22], and telomere dysfunction [43]. Here, we show 
that autophagy favors the induction of senescence in serum-starved fibroblasts. Inhibiting 
autophagy with 3-MA, LY, or siATG7 lowered the expression of senescence markers. We also 
identified a novel signaling pathway linking autophagy to senescence. We previously showed 
that the inhibition of autophagy with ATG7 silencing in serum-starved fibroblasts reduced 
MTORC2 activity [16]. We are now showing that MTORC2 activity, induced by prolonged SS, 
is pivotal to the expression of senescence markers. Inhibiting MTORC2 activity with rapamycin 
or siRICTOR lowered the expression of senescence markers. Thirdly, we demonstrated the 
importance of ROS in this process. Inhibition of ROS production in serum-starved fibroblasts 
with NAC or GSH, 2 ROS scavengers, curbed MTORC2 activation, and concomitantly limited 
senescence activation. ROS production occurs rapidly after the initiation of the autophagic 
response, whereas MTORC2 activation develops as a long-term response, suggesting a series of 
molecular intermediates between the two. Characterizing the detailed molecular machinery 




ROS are essential for the regulation of many cellular processes, and they are known inducers of 
autophagy [44]. For example, they are essentials for ATG4A (autophagy related 4A cysteine 
peptidase) activation and phagophore elongation [45]. ROS act as signaling molecules, and 
many enzymatic activities are known to be regulated by their redox status. They also control 
protein phosphatases and protein kinases, such as PTEN (phosphatase and tensin homolog) and 
AKT1 [46]. MTORC2 activity is also sensitive to the redox state [47]. Based on these 
observations and our present findings, it is plausible that MTORC2 activation, in long-term 
serum-starved fibroblasts, is linked with cellular ROS levels. This finding is in line with 
previously described roles of the MTOR pathway in regulating senescence-associated 
phenotypes [42]. We also noted that ROS production is rapidly and sustainably elevated in 
serum-starved fibroblasts while MTORC2 activation develops after 2 d of SS, suggesting a 
complex signaling cascade between autophagy, ROS production, and MTORC2 activation.  
Nonetheless, ROS chelation with NAC and GSH inhibits MTORC2 activity, myofibroblast 
differentiation, and senescence, demonstrating the pivotal role for ROS in triggering this 
complex cascade. The mechanisms of ROS production after prolonged SS remain uncertain. 
Mitochondria are considered the principal source of ROS required for autophagy induction, and 
nutrient deprivation induces energetic stress, which, in turn, increases ATP demand and causes 
mitochondrial overburden in the face of adverse conditions [44]. Consequently, electron leakage 
and ROS production increase. Conversely, long-term ROS production may culminate in 
mitochondrial dysfunction. Indeed, high ROS levels are associated with oxidative stress, a 
known stimulus of senescence [25], and myofibroblast differentiation [39,48].  
Consequently, mitochondria depolarize and fragment to facilitate their elimination by 
mitophagy to reduce ROS production and promote cell survival [49]. In our model, we showed 
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that long-term serum-starvation induces mitochondrial fragmentation. NAC restored the 
mitochondrial hyperfused network suggesting that increased ROS production induced by 
serum-starvation damages mitochondria, while treatment with an ROS scavenger can prevent 
mitochondrial dysfunction in autophagic fibroblasts. Oxidative stress harms cellular 
components, such as proteins, lipids, and DNA. The DNA damage is sensed by TP53, which 
activates DNA damage response signaling that can potentially lead to senescence, often via 
CDKN1A induction [38,50].  
In the present experimental setting, NAC and GSH inhibited senescence induction and 
myofibroblast differentiation. NAC and GSH also suppressed autophagy induction. These data 
highlight the dichotomic impact of autophagy on senescence induction and myofibroblast 
differentiation. As mentioned earlier, oxidative stress causes damage. It is possible that 
cumulative mitochondrial DNA damage causes mitochondrial dysfunction and enhances ROS 
levels, with autophagy being insufficient to restrain it. ROS then continuously damages nuclear 
DNA leading to senescence and myofibroblast differentiation. 
The link between cellular senescence and myofibroblast differentiation has long remained 
elusive. By using genetic inhibition of senescence pathways, we demonstrated negative 
regulation of senescence on myofibroblast differentiation, as inhibition of senescence 
significantly increased the expression of ACTA2. Also, evaluation of senescence and 
myofibroblast markers in chronically serum-starved fibroblasts showed that the 2 programs 
occur in largely mutually exclusive cell subpopulations. These results are in line with the study 
showing that mice with ccn1 (cellular communication network factor 1)-null hepatocytes have 
non-senescent hepatic stellate cells (HSC) and increased fibrotic response [10]. It has also been 
demonstrated, in a murine skin wound closure model, that senescent fibroblasts appear early in 
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the wound and accelerate wound closure by inducing myofibroblasts differentiation via 
secretion of Pdgfa (Platelet-derived growth factor subunit A) [8]. However, in the same study, 
depletion of senescent cells resulted in excessive fibrosis, suggesting a role of cellular 
senescence in limiting excessive myofibroblast differentiation [8]. Our results can also reconcile 
the work of Hernandez-Gea et al., showing that autophagy enhances liver fibrosis with the work 
of Araya and colleagues [51] demonstrating an inhibitory function for autophagy in 
myofibroblast differentiation of pulmonary fibroblasts. We described a new signaling pathway 
linking autophagy to senescence and myofibroblast differentiation. MTORC2 activity induced 
by persistent SS determines the fate of cells either towards senescence or myofibroblast 
differentiation independently of MTORC1. Further studies will be needed to delineate the 
MTORC2 target signaling pathways leading to either senescence or myofibroblast 
differentiation. 
In summary, our results demonstrate that in a serum-depleted environment, fibroblasts induce 
cell cycle arrest and autophagy to adapt to stress. If these stressful conditions are sustained, ROS 
production persists, favoring MTORC2 activation, and leading to long-term cell cycle arrest, 
senescence induction, or myofibroblast differentiation in distinct cell subpopulations. Activation 
of cellular senescence negatively regulates myofibroblast differentiation, likely as a means of 
avoiding excessive myofibroblast accumulation and fibrosis (Fig. 7). 
 




WI-38 human fibroblasts from normal embryonic lung tissue were purchased from the American 
Type Culture Collection (CCL-75), grown in fibroblast basal medium (Lonza, CC-3131) 
supplemented with 10% inactivated fetal bovine serum (Wisent, 090150; normal growth 
medium [N]) and used between passages 6 and 8. Human Lung Fibroblast (HLF) from adult 
were purchased from Cell Applications (506-05A), grown in fibroblast basal medium 
supplemented with 10% inactivated fetal bovine serum and used at passage 6. For growth factor 
deprivation, the fibroblasts were washed twice with phosphate-buffered saline (PBS; Wisent, 
311-425-CL) before being exposed to serum-free medium (SS). Media were replaced every 
other day. The cells were plated at a density of 20,000 cells/cm2 in 6-well plates and exposed to 




Cellular proteins were extracted, separated by electrophoresis, transferred to nitrocellulose 
membranes (Bio-Rad Laboratories, 162-0115) and probed, as described previously [16,52-54]. 
The antibodies used for immunoblotting were anti-ACTA2/αSMA (Sigma-Aldrich, A2547), 
anti-MAP1LC3B/LC3B (Novus, NB600-1384), anti-human SQSTM1/p62 (Cell Signaling 
Technology, 8025), anti-p-AKT1 (Ser473; Cell Signaling Technology, 9271), anti-AKT1 (Cell 
Signaling Technology, 9272), anti-RICTOR (Cell Signaling Technology, 2114), anti-RPTOR 
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(Cell Signaling Technology, 2280), anti-ATG7 (R&D Systems, MAB6608), anti-CDKN1A/p21 
(BD Biosciences, BD556430) and anti-CDKN2A/p16 (BD Biosciences, BD551153). 
Membranes were stained with Ponceau S Red (Sigma, P-3504) as loading control, and after 
initial probing, they were stripped and re-probed with anti-TUBA (tubulin alpha; Calbiochem, 
CP06). Densitometric analyses were conducted with AlphaImager, version 3.2 (Alpha Innotech 




Cytochemical SA-GLB1/β-gal detection was done as described previously [29]. In brief, cells 
were washed with PBS, fixed in formalin (Sigma-Aldrich, HT5014), washed, and incubated 
overnight at 37°C with staining solution containing X-gal at 1 mg/ml (Invitrogen, 15520-034), 
pH 6.0. 
 
Analysis of ROS production. 
 
ROS production was measured on adherent cells by fluorescent microplate reader after staining 
with CM-H2DCFDA (Molecular Probes, C6827), a dye which becomes fluorescent after 
oxidation by ROS. Briefly, cells were plated at 25,000 cells/well in 96-well dark-clear bottom 
plates. The next day, the wells were washed twice with PBS, and the cells were stained with 5 
μM CM-H2DCFDA in PBS at 37°C for 30 min, then the wells were washed once with PBS and 
incubated with treatment medium for the desired time period (1 or 4 h). The plates were read by 
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fluorescent plate reader (BMG Labtech, FLUOstar OPTIMA) at excitation wavelength of 495 




WI38 were grown in 96-well Fluorescence Black Plate (Corning, 29444-008), after serum-
starved for 7 d, they were rinsed twice with PBS and fixed with 2% formaldehyde + 0.2% 
glutaraldehyde. Plates were then incubated in 33 mM C12FDG (Invitrogen, I2904) in PBS to 
determinate SA-GLB1/β-gal activity. Nuclei were stained with Hoechst 33342 (2′‐[4‐
ethoxyphenyl]‐5‐[4‐methyl‐1‐piperazinyl]‐2.5′‐bi‐1H‐benzimidazole) (Ho; Sigma-Aldrich, 
B2261). The cells were then visualized under a Zeiss cell observer SD microscope (Carl Zeiss 
Canada Ltd, Toronto, ON, Canada) and the locations of captured area were saved. The cells 
were permeabilized with 0.1% Triton X-100 (Sigma-Aldrich, T9284) in PBS for 15 min. Plates 
were blocked with PBS-10% goat serum (Sigma-Aldrich, D9759), 0.1% Tween 20 (Sigma-
Aldrich, P1379) for 15 min. For ACTA2 staining, cells were incubated with mouse monoclonal 
antibody (Sigma-Aldrich, A2547) 2 h and then Alexa Fluor 555-labeled anti-mouse antibody 
(Molecular Probes, A21203) for 40 min at room temperature in blocking buffer. The cells were 
then visualized under a Zeiss cell observer SD microscope at the same locations as C12FDG 
staining. The images taken at the same locations were then aligned using Olympus Visiomorph 
(Pittsburgh, PA, USA), and FIJI softwares. Quantification was done using FIJI softwares. 
For assessment of mitochondrial morphology, WI38 were plated at 25,000 cells/well in 6-well 
plate. Once the cells reached confluence, they were incubated under serum starvation in the 
presence of NAC or vehicle for 4 or 7 d. Thirty minutes before the end of the treatment, 500 nM 
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of MitoTracker Deep Red FM (Cell Signaling Technology, 8778S) was added to the wells. The 
cells were then washed with PBS and fixed with 4% paraformaldehyde for 15 min. Nuclei were 
stained with DAPI (4',6-Diamidino-2-Phenylindole, Dilactate; Invitrogen, D3571). Confocal 
images were acquired on an Olympus FV1000MPE confocal microscope (Pittsburgh, PA, USA) 
using a UPLSAPO 60x/1.35 Oil objective. Excitation system was performed using a 405 diode 
laser for DAPI, and a 635 nm diode laser for MitoTracker Deep Red FM (Invitrogen, M7513) 
using a sequential acquisition at 400 Hz scan speed. Detection bandwidth was 415-478 nm for 
DAPI and 571-765 nm for MitoTracker Deep Red FM. Images were acquired with the Fluoview 
1000 MP software. Final images are 12 bits, 2048x2048 with a zoom factor 3 and scale is 
specified in the figure’s legends. Images were analyzed using FIJI software (NIH).  
 
Small interfering RNAs.  
 
For ATG7 silencing, fibroblasts grown in normal conditions were harvested by trypsinization 
and separated in aliquots of 1.5 million cells. Separate aliquots were transfected with siATG7 
(Dharmacon, L-020112-00), or siControl (Dharmacon, D-001810-03). We used the Amaxa 
Nucleofector electroporator (Amaxa, Gaithersburg, MD, USA) and Nucleofector 
electroporation kit for WI-38 cells (Lonza, VCA-1001) according to the manufacturer’s 
guidelines. The final concentration of siRNA was 150 pmol of siRNA/reaction. After 
electroporation, each cellular aliquot was plated in 2 wells of a 6-well plate in normal medium 
for 24 h. The media were then changed for the experimental condition (media without serum) 
after 2 washes with PBS. For 4 d in SS, the media were changed on day 2. For RICTOR and 
RPTOR silencing, fibroblasts were plated in 6-well plated at 20000 cells/cm2, after grown in 
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normal condition for 24 h, transfection solution with oligofectamine (Invitrogen, 12252-011) 
and siRNA was prepared in RPMI according to the manufacturer’s guidelines, final 
concentrations of siRICTOR (Dharmacon, L-016984-00), siRPTOR (Dharmacon, L-004107-00) 
or siControl (Ctl; Dharmacon, D-001810-03) were 200 nM, cells were washed with 2X PBS 
and incubated with RPMI-based transfection solution, for 4 d in SS, the transfection solution 




Gene depletion lenti-vectors were generated by inserting W51-1 shRNA cassettes (gateway 
transfer) inserted into the W17-1 destination lentivector (Addgene, 17387, Éric Campeau  and 
17295, Éric Campeau respectively [55]). The W51-1 shRNA cassettes containing either 
shRNATP53 (target 5-GACTCCAGTGGTAATCTAC-3 [56]), shRNACDKN2A (target 5-
AACTATTCGGTGCGTTG-3 [5]) (Addgene, 22258, Eric Campeau) or shRNAGFP (5-
GCTGGAGTACAACTACAAC-3 [56]). Lentivirus production and infection was done as 
previously described [55,57]. Briefly, packaging vectors and shRNA lenti-vectors were co-
transfected into 293FT cells to produce infectious virus. Virus titers were adjusted to infect 
~90% of the target proliferating WI38 cells at PD35. Following shRNAGFP or shRNATP53 
infections, shRNATP53-infected cells were infected a second time with shRNACDKN2A to 
generate shTP53CDKN2A cells. The infected cell populations were selected using 100 μg/ml 






LY294002 (LY, 440202) and 3-methyladenine (3-MA, 189490) were purchased from 
Calbiochem. Rapamycin (R; R0395), N-acetyl-L-cysteine (NAC; A9165), and L-glutathione 
reduced (GSH; G6013) were purchased from Sigma-Aldrich and zeocin (46-0509) from 




The results, expressed as means ± SEM, were analyzed by unpaired Student’s t-test, the Mann-
Whitney test or ANOVA with post-hoc Bonferroni as appropriate. P<0.05 was considered 
significant for all tests. 
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Figure 1. Serum starvation (SS) induces senescence in fibroblasts. (A) Left panel: 
Representative immunoblots of SQSTM1, ACTA2, CDKN1A and TUBA protein levels 
in WI-38 fibroblasts exposed to SS. Right panel: Densitometric analysis of SQSTM1 
(**P<0.01, 4 h vs 2 d (d); **P<0.01, 4 h vs 4 d, n=5), ACTA2 (***P<0.005, 2 d vs 4 d, 
n=5) and CDKN1A (*P<0.05, 0 vs 4 h, n=4) relative to TUBA. Data are presented as 
mean ± SEM (B) Representative immunoblots of SQSTM1, ACTA2, CDKN2A and 
TUBA protein levels in WI-38 fibroblasts exposed to SS or grown under N at 4 and 7 
d (n=2). (C) Cytochemical evaluation of the senescence marker SA-GLB1/β-gal 
activity of cells grown in N or maintained SS for 1, 3 or 7 d. Zeocin (Zeo) in N (50 
ug/ml) served as a positive control. Data are presented as % of SA-GLB1/β-gal-positive 
cells (mean ± SEM; *P<0.05, 0 vs SS 7 d; ****P<0.0001, 0 vs zeocin 7 d, n=3) Scale 
bar: 50 µm. 
 
Figure 2. Autophagy induces senescence in serum-starved (SS) fibroblasts. (A) Upper 
left panel: Representative immunoblots of MAP1LC3B-I and -II protein levels in WI-
38 fibroblasts starved in the presence of 3-MA (1 mM) or vehicle (V) for 4 h. Upper 
right panel: Densitometric analysis of MAP1LC3B-II relative to MAP1LC3B-I 
(*P<0.05, n=3). Lower left panel: Representative immunoblots of SQSTM1, ACTA2, 
CDKN1A, CDKN2A and TUBA protein levels in SS WI-38 fibroblasts and incubated 
with 3-MA (1 mM) or V for 4 d. Lower right panel: Densitometric analysis of SQSTM1 
(*P<0.05), ACTA2 (****P<0.0001), CDKN1A (*P<0.05) and CDKN2A (*P<0.05) 
relative to TUBA (n=3). (B) Upper left panel: Representative immunoblots of 
MAP1LC3B-I and -II protein levels in SS WI-38 fibroblasts in the presence of LY (5 
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µM) or V for 4 h. Upper right panel: Densitometric analysis of MAP1LC3B-II relative 
to MAP1LC3B-I (**P<0.01, n=3). Lower left panel: Representative immunoblots of 
SQSTM1, ACTA2, CDKN1A, CDKN2A and TUBA protein levels in SS WI-38 
fibroblasts and incubated with LY (5 µM) or V for 4 d. Lower right panel: Densitometric 
analysis of SQSTM1 (*P<0.05), ACTA2 (*P<0.05), CDKN1A (*P<0.05), CDKN2A 
(**P<0.01) relative to TUBA (n=3). (C) Left panel: Representative immunoblots of 
ATG7, MAP1LC3B-I and -II, SQSTM1, ACTA2, CDKN2A and TUBA protein levels 
in SS WI-38 fibroblasts for 4 d post-nucleofection with control siRNA (siCtl) or 
siATG7. Right panel: Densitometric analysis of ATG7 (***P<0.001), MAP1LC3B-II:I 
ratios (*P<0.05), SQSTM1 (*P<0.05), ACTA2 (*P<0.05) and CDKN2A (*P<0.05) 
protein levels relative to TUBA in WI-38 fibroblasts silenced for ATG7 expression 
(n=4). All densitometric analysis are presented as mean ± SEM (D) Cytochemical 
evaluation of the senescence marker SA-GLB1/β-gal activity in SS cells and incubated 
with 3-MA (1 mM) or V for 7 d. Data are presented as % of SA-GLB1/β-gal-positive 
cells (mean ± SEM; *P<0.05, n=3) Scale bar: 50 µm. (E) Cytochemical evaluation of 
the senescence marker SA-GLB1/β-gal activity in SS cells and incubated with LY (5 
µM) or V for 7 d. Data are presented as % of SA-GLB1/β-gal-positive cells (mean ± 
SEM; ***P<0.001, n=3) Scale bar: 50 µm. 
 
Figure 3. Senescence induced by serum starvation (SS) depends on MTORC2 
signaling. (A) Left panel: Representative immunoblots of western blots showing 
MAP1LC3B-I and –II, ACTA2, AKT1 Ser473 phosphorylation (AKT1 p), total AKT1 
(AKT1 t), CDKN1A, CDKN2A and TUBA protein levels in WI-38 fibroblast exposed 
to SS for 4 d in the presence of R (10 nM) or V. Right panel: Densitometric analysis of 
MAP1LC3B-II relative to MAP1LC3B-I (*P<0.05), ACTA2 relative to TUBA 
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(*P<0.05), AKT1 p relative to AKT1 t (*P<0.05), CDKN1A (*P<0.05) and CDKN2A 
(**P<0.05) relative to TUBA (n=3). (B) Left panel: Representative immunoblots of 
RICTOR, RPTOR, AKT1 p, AKT1 t, ACTA2, CDKN1A, CDKN2A and TUBA protein 
levels in SS WI-38 fibroblats for 4 d after transfection with siCtl, siRICTOR or 
siRPTOR. Right panel: Densitometric analysis of AKT1 p relative to AKT1 t, ACTA2 
relative to TUBA, CDKN1A and CDKN2A relative to TUBA (*P<0.05, **P<0.01, 
***P<0.001, and ****P<0.0001 values compared to siCtl, n=3). All densitometric 
analysis are expressed as mean ± SEM (C) Cytochemical evaluation of the senescence 
marker SA-GLB1/β-gal activity in SS cells and incubated with R (10 nM) or V for 7 d. 
Data are presented as % of SA-GLB1-positive cells (mean ± SEM; ****P<0.0001, n=3) 
Scale bar: 40 µm. (D) Cytochemical evaluation of the senescence marker SA-GLB1/β-
gal activity in SS cells and transfected with siCtl, siRICTOR or siRPTOR for 7 d. Data 
are presented as % of SA-GLB1/β-gal-positive cells (mean ± SEM; *P<0.05 between 
siRICTOR or siRPTOR and siRICTOR+siRPTOR and **P<0.01, ***P<0.001 values 
compared to siCtl, n=3) Scale bar: 40 µm. 
 
Figure 4. ROS are required for autophagy-induced MTORC2 activation leading to 
senescence. (A) Upper panel: Starvation elicits ROS production in WI-38 fibroblasts. 
Quantification of ROS production in WI-38 fibroblasts stained with CM-H2DCFDA 
and cultured for 1 h in the N, SS, SS + 10 mM NAC, SS + 100 µM GSH or 500 µM 
hydrogen peroxide (H2O2; as positive control). Fluorescence is expressed as mean ± 
SEM (**P<0.01 N vs SS, NAC vs SS and *P<0.05 GSH vs SS, in triplicate). Lower 
panel: Stained cells were incubated for 4 h in the conditions described in A before 
fluorescence was measured (***P<0.001 N vs SS, **P<0.01 NAC vs SS and GSH vs 
SS, in triplicate). (B) Left panel: Representative immunoblots of SQSTM1, ACTA2, 
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CDKN1A, CDKN2A and TUBA protein levels in WI-38 fibroblasts exposed to N, SS, 
SS + NAC 10 mM or SS + 100 µM GSH for 4 d. Right panels: Densitometric analysis 
of SQSTM1, ACTA2, CDKN1A and CDKN2A relative to TUBA. Data are presented 
as mean ± SEM (*P<0.05, **P<0.01, ***P<0.001, and ****P<0.0001 values compared 
to SS condition, n=4). (C) Cytochemical evaluation of the senescence marker SA-
GLB1/β-gal activity in SS cells or SS + NAC 10 mM or SS + 100 µM GSH for 7 d. 
Data are presented as % of SA-GLB1/β-gal-positive cells (mean ± SEM; ***p<0.001 
and ****P<0.0001 compared to SS cells, n=3) Scale bar: 40 µm. (D) Upper panel: 
Representative immunoblots of AKT1 p and AKT1 t in WI-38 fibroblasts exposed to 
N, SS, SS + 10 mM NAC or SS + 100 µM GSH for 2 d. Lower panel: Densitometric 
analysis of AKT1 p relative to AKT1 t compared to serum starved cells (*P<0.05, n=3). 
Data are presented as mean ± SEM.  
Figure 5. Inhibition of senescence leads to upregulated myofibroblast differentiation. 
(A) Left panel: Representative immunoblots of AKT1 p, AKT1 t, ACTA2, CDKN1A, 
CDKN2A and TUBA protein levels in WI-38 fibroblasts transfected with shGFP or 
shTP53CDKN2A plasmids exposed to N or SS for 4 d. Right panels: Densitometric 
analysis of AKT1 p relative to AKT1 t, ACTA2, CDKN1A and CDKN2A relative to 
TUBA. Data are presented as mean ± SEM (*P<0.05, **P<0.01, ***P<0.001, and 
****P<0.0001 values compared to shGFP-SS condition, n=5). (B) Cytochemical 
evaluation of the senescence marker SA-GLB1/β-gal activity in transfected cells 
serum-starved for 7 d. Data are presented as % of SA-GLB1/β-gal-positive cells (mean 
± SEM; **P<0.001 value compared to shGFP-SS condition, n=3) Scale bar: 50 µm.  
Figure 6. Cellular senescence and myofibroblast differentiation are not concomitantly 
activated in the same cells. (A) Representative photo of C12FGD and ACTA2 
costaining in SS WI38 for 7 d, showing ACTA2 staining (upper left panel), SA-
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GLB1/β-gal activity (upper right panel), cell nuclei staining by Ho (lower left panel) 
and overlap of 3 images (lower right panel). Scale bar: 100 µm (B) Quantification of 
C12FGD and ACTA2 costaining. Numbers of nuclei stained by Ho were used as total 
numbers of cells. Data were shown as mean percentage of ACTA2, SA-GLB1/β-gal or 
double-positive cell in total cells (n=4). 
Figure 7. Proposed working model. Serum starvation induces ROS production which 
leads to increased autophagy. Sustained autophagy induces MTORC2 activity in 
fibroblasts. The activation of MTORC2 determines the fate of cells either towards 
senescence or myofibroblast differentiation. The factors downstream of MTORC2 that 
control the choice between either senescence or myofibroblast differentiation remain to 
be delineated. Senescence sustains MTORC2 activation while preventing 
myofibroblast differentiation. 
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Figure 6 Cellular senescence and myofibroblast differentiation are not concomitantly activated in the same cells. 
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